Global Influenza Diagnostics Market to Reach $3.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Influenza Diagnostics estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. RIDT, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RT-PCR segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U. S. Market is Estimated at $685 Million, While China is Forecast to Grow at 8% CAGR
The Influenza Diagnostics market in the U. S. is estimated at US$685 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$755.1 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
Cell Culture Segment to Record 4.6% CAGR
In the global Cell Culture segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$245.6 Million in the year 2020 will reach a projected size of US$326.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$484 Million by the year 2027, while Latin America will expand at a 5.6% CAGR through the analysis period. We bring years of research experience to this 6th edition of our report. The 278-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
Alere, Inc.
Analytik Jena AG
Becton, Dickinson and Company
DiaSorin SpA
F. Hoffmann-La Roche AG
Luminex Corporation
Meridian Bioscience, Inc.
Quidel Corporation
SA Scientific, Ltd.
Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
TABLE 1: Influenza Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Influenza Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Influenza Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: RIDT (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: RIDT (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: RIDT (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: RT-PCR (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: RT-PCR (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: RT-PCR (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Cell Culture (Test Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Cell Culture (Test Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Cell Culture (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Other Test Types (Test Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: Other Test Types (Test Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: Other Test Types (Test Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Hospitals (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 17: Hospitals (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
TABLE 18: Hospitals (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: POCT (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
TABLE 20: POCT (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
TABLE 21: POCT (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
TABLE 22: Laboratories (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
TABLE 23: Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
TABLE 24: Laboratories (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Influenza Diagnostics Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 25: United States Influenza Diagnostics Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 26: Influenza Diagnostics Market in the United States by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 27: United States Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 28: United States Influenza Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 29: Influenza Diagnostics Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
TABLE 30: Influenza Diagnostics Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
TABLE 31: Canadian Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 32: Canadian Influenza Diagnostics Historic Market Review by Test Type in US$ Million: 2012-2019
TABLE 33: Influenza Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
TABLE 34: Canadian Influenza Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 35: Influenza Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 36: Canadian Influenza Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
TABLE 37: Japanese Market for Influenza Diagnostics: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 38: Influenza Diagnostics Market in Japan: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 39: Japanese Influenza Diagnostics Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
TABLE 40: Japanese Demand Estimates and Forecasts for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 41: Japanese Influenza Diagnostics Market in US$ Million by End-Use: 2012-2019
TABLE 42: Influenza Diagnostics Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
TABLE 43: Chinese Influenza Diagnostics Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 44: Influenza Diagnostics Historic Market Analysis in China in US$ Million by Test Type: 2012-2019
TABLE 45: Chinese Influenza Diagnostics Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 46: Chinese Demand for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 47: Influenza Diagnostics Market Review in China in US$ Million by End-Use: 2012-2019
TABLE 48: Chinese Influenza Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Influenza Diagnostics Market: Competitor Market Share Scenario (in %)for 2019 & 2025
Market Analytics
TABLE 49: European Influenza Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 50: Influenza Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 51: European Influenza Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 52: European Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 53: Influenza Diagnostics Market in Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 54: European Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 55: European Influenza Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 56: Influenza Diagnostics Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 57: European Influenza Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
TABLE 58: Influenza Diagnostics Market in France by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 59: French Influenza Diagnostics Historic Market Scenario in US$ Million by Test Type: 2012-2019
TABLE 60: French Influenza Diagnostics Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
TABLE 61: Influenza Diagnostics Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
TABLE 62: French Influenza Diagnostics Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 63: French Influenza Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
TABLE 64: Influenza Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 65: German Influenza Diagnostics Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 66: German Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 67: Influenza Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 68: German Influenza Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 69: Influenza Diagnostics Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
TABLE 70: Italian Influenza Diagnostics Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 71: Influenza Diagnostics Historic Market Analysis in Italy in US$ Million by Test Type: 2012-2019
TABLE 72: Italian Influenza Diagnostics Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 73: Italian Demand for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 74: Influenza Diagnostics Market Review in Italy in US$ Million by End-Use:2012-2019
TABLE 75: Italian Influenza Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
TABLE 76: United Kingdom Market for Influenza Diagnostics: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 77: Influenza Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 78: United Kingdom Influenza Diagnostics Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
TABLE 79: United Kingdom Demand Estimates and Forecasts for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 80: United Kingdom Influenza Diagnostics Market in US$ Million by End-Use: 2012-2019
TABLE 81: Influenza Diagnostics Market Share Shift in the United Kingdom by End-Use:2012 VS 2020 VS 2027
SPAIN
TABLE 82: Spanish Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 83: Spanish Influenza Diagnostics Historic Market Review by Test Type in US$ Million: 2012-2019
TABLE 84: Influenza Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
TABLE 85: Spanish Influenza Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 86: Influenza Diagnostics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 87: Spanish Influenza Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
RUSSIA
TABLE 88: Russian Influenza Diagnostics Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 89: Influenza Diagnostics Market in Russia by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 90: Russian Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 91: Russian Influenza Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 92: Influenza Diagnostics Historic Demand Patterns in Russia by End-Use in US$ Million for 2012-2019
TABLE 93: Influenza Diagnostics Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 94: Rest of Europe Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 95: Influenza Diagnostics Market in Rest of Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 96: Rest of Europe Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 97: Rest of Europe Influenza Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 98: Influenza Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 99: Rest of Europe Influenza Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 100: Asia-Pacific Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 101: Influenza Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
TABLE 102: Asia-Pacific Influenza Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
TABLE 103: Influenza Diagnostics Market in Asia-Pacific by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 104: Asia-Pacific Influenza Diagnostics Historic Market Scenario in US$ Million by Test Type: 2012-2019
TABLE 105: Asia-Pacific Influenza Diagnostics Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
TABLE 106: Influenza Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
TABLE 107: Asia-Pacific Influenza Diagnostics Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 108: Asia-Pacific Influenza Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
AUSTRALIA
TABLE 109: Influenza Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 110: Australian Influenza Diagnostics Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 111: Australian Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 112: Influenza Diagnostics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 113: Australian Influenza Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 114: Influenza Diagnostics Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027
INDIA
TABLE 115: Indian Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 116: Indian Influenza Diagnostics Historic Market Review by Test Type in US$ Million: 2012-2019
TABLE 117: Influenza Diagnostics Market in India: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
TABLE 118: Indian Influenza Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 119: Influenza Diagnostics Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 120: Indian Influenza Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
SOUTH KOREA
TABLE 121: Influenza Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 122: South Korean Influenza Diagnostics Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 123: Influenza Diagnostics Market Share Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027
TABLE 124: Influenza Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
TABLE 125: South Korean Influenza Diagnostics Historic Market Analysis in US$ Million by End-Use: 2012-2019
TABLE 126: Influenza Diagnostics Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
TABLE 127: Rest of Asia-Pacific Market for Influenza Diagnostics: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 128: Influenza Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 129: Rest of Asia-Pacific Influenza Diagnostics Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
TABLE 130: Rest of Asia-Pacific Demand Estimates and Forecasts for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 131: Rest of Asia-Pacific Influenza Diagnostics Market in US$ Million by End-Use: 2012-2019
TABLE 132: Influenza Diagnostics Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
LATIN AMERICA
TABLE 133: Latin American Influenza Diagnostics Market Trends by Region/Country in US$ Million: 2020-2027
TABLE 134: Influenza Diagnostics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 135: Latin American Influenza Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
TABLE 136: Latin American Influenza Diagnostics Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 137: Influenza Diagnostics Historic Market Analysis in Latin America in US$ Million by Test Type: 2012-2019
TABLE 138: Latin American Influenza Diagnostics Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 139: Latin American Demand for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 140: Influenza Diagnostics Market Review in Latin America in US$ Million by End-Use: 2012-2019
TABLE 141: Latin American Influenza Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
ARGENTINA
TABLE 142: Argentinean Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 143: Influenza Diagnostics Market in Argentina in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 144: Argentinean Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 145: Argentinean Influenza Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 146: Influenza Diagnostics Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 147: Argentinean Influenza Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
BRAZIL
TABLE 148: Influenza Diagnostics Market in Brazil by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 149: Brazilian Influenza Diagnostics Historic Market Scenario in US$ Million by Test Type: 2012-2019
TABLE 150: Brazilian Influenza Diagnostics Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
TABLE 151: Influenza Diagnostics Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2020-2027
TABLE 152: Brazilian Influenza Diagnostics Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 153: Brazilian Influenza Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
MEXICO
TABLE 154: Influenza Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 155: Mexican Influenza Diagnostics Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 156: Mexican Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 157: Influenza Diagnostics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 158: Mexican Influenza Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 159: Influenza Diagnostics Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
TABLE 160: Rest of Latin America Influenza Diagnostics Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 161: Influenza Diagnostics Market in Rest of Latin America by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 162: Rest of Latin America Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 163: Rest of Latin America Influenza Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 164: Influenza Diagnostics Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2012-2019
TABLE 165: Influenza Diagnostics Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
MIDDLE EAST
TABLE 166: The Middle East Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 167: Influenza Diagnostics Market in the Middle East by Region/Country in US$ Million: 2012-2019
TABLE 168: The Middle East Influenza Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
TABLE 169: The Middle East Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 170: The Middle East Influenza Diagnostics Historic Market by Test Type in US$ Million: 2012-2019
TABLE 171: Influenza Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Test Type for 2012,2020, and 2027
TABLE 172: The Middle East Influenza Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 173: Influenza Diagnostics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 174: The Middle East Influenza Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
IRAN
TABLE 175: Iranian Market for Influenza Diagnostics: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 176: Influenza Diagnostics Market in Iran: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 177: Iranian Influenza Diagnostics Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
TABLE 178: Iranian Demand Estimates and Forecasts for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 179: Iranian Influenza Diagnostics Market in US$ Million by End-Use:2012-2019
TABLE 180: Influenza Diagnostics Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027
ISRAEL
TABLE 181: Israeli Influenza Diagnostics Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 182: Influenza Diagnostics Market in Israel in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 183: Israeli Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 184: Israeli Influenza Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 185: Influenza Diagnostics Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 186: Israeli Influenza Diagnostics Market Share Analysis by End-Use:2012 VS 2020 VS 2027
SAUDI ARABIA
TABLE 187: Saudi Arabian Influenza Diagnostics Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 188: Influenza Diagnostics Historic Market Analysis in Saudi Arabia in US$ Million by Test Type: 2012-2019
TABLE 189: Saudi Arabian Influenza Diagnostics Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 190: Saudi Arabian Demand for Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 191: Influenza Diagnostics Market Review in Saudi Arabia in US$ Million by End-Use: 2012-2019
TABLE 192: Saudi Arabian Influenza Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
TABLE 193: Influenza Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 194: United Arab Emirates Influenza Diagnostics Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 195: Influenza Diagnostics Market Share Distribution in United Arab Emirates by Test Type: 2012 VS 2020 VS 2027
TABLE 196: Influenza Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
TABLE 197: United Arab Emirates Influenza Diagnostics Historic Market Analysis in US$ Million by End-Use: 2012-2019
TABLE 198: Influenza Diagnostics Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
TABLE 199: Influenza Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 200: Rest of Middle East Influenza Diagnostics Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 201: Rest of Middle East Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 202: Influenza Diagnostics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 203: Rest of Middle East Influenza Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 204: Influenza Diagnostics Market Share Distribution in Rest of Middle Eastby End-Use: 2012 VS 2020 VS 2027
AFRICA
TABLE 205: African Influenza Diagnostics Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 206: Influenza Diagnostics Market in Africa by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 207: African Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
TABLE 208: African Influenza Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 209: Influenza Diagnostics Historic Demand Patterns in Africa by End-Use in US$ Million for 2012-2019
TABLE 210: Influenza Diagnostics Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 38
Note: Product cover images may vary from those shown
![Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes) - Global Forecast to 2027 - Product Image](http://d386vep05x5edh.cloudfront.net/product_images/9270/9270113_60px_jpg/influenza_diagnostics_market_by_test_type_[traditional_ridt_direct_fluorescent_antibody_viral_culture_serology_molecular_[rtpcr_inaat_nasba_lamp]_end_user_hospitals_laboratories_academics_research_institutes_global_forecast_to_2027.jpg)
